[BMJ Publishing Group Ltd IGCS Annual 2019 Meeting Abstracts - ()] Plenary sessions - 33â Olaparib monotherapy versus (VS) chemotherapy for germline BRCA-mutated (GBRCAM) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (PTS): phase III solo3 trial
Penson, RT, Valencia, RV, Cibula, D, Colombo, N, III, CL, Bidzinski, M, Kim, JW, Nam, JH, Madry, R, Hernández, CH, Mora, P, Ryu, SY, Milenkova, T, Lowe, e, Barker, L, Scambia, GDOI:
10.1136/ijgc-2019-igcs.33
File:
PDF, 68 KB